US4879216A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Specific antibody against heart muscle light chains, a process for the preparation thereof and a reagent containing it
Assignee: Roche Diagnostics GmbH
•
Filing: 1988-03-08
•
Granted: 1989-11-07
•
Expires: 2008-03-08
Abstract
Abstract The present invention provides a specific antibody against heart muscle light chains (HMLC) with a cross-reactivity against skeletal muscle light chains (SMLC) of less than 5%. The present invention also provides a process for the preparation of this specific antibody, wherein a mammal is immunized with HMLC I and/or HMLC II and the crude serum is recovered and subjected to an immunosorptive purification on an SMLC immune adsorbent based on silicate. Furthermore, the present invention provides a reagent for the determination of HMLC which contains antibodies against HMLC according to the present invention.
Inventors
- 👤 Klaus Hallermayer
- 👤 Siegfrid Looser
- 👤 Hugo Katus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 07:59
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/551; G01N33/552; C; C07; C07K; C07K16/00; C07K16/18; G01N33/54353; Y; Y10; Y10S; Y10S436/00; Y10S436/80; Y10S436/804; Y10S436/811; Y10S436/815; Y10S530/00; Y10S530/808; Y10S530/809
Claims Analysis
Total Claims: 26
Claim 1
Independent Claim
28 words
Substantially pure antibody which specifically binds to heart muscle myosin light chain and which has a cross reactivity of less than 5% against skeletal muscle myosin light chain.
Claim 2
Dependent Claim
28 words
Substantially pure antibody which specifically binds to heart muscle myosin light chain and which has a cross reactivity of less than 5% against skeletal muscle myosin light chain.
Claim 3
Dependent Claim
21 words
Antibody of claim 1, wherein said antibody has a cross reactivity of less than 2% against skeletal muscle myosin light chain.
Claim 4
Dependent Claim
21 words
Antibody of claim 1, wherein said antibody has a cross reactivity of less than 1% against skeletal muscle myosin light chain.
Claim 5
Dependent Claim
68 words
Antibody of claim 1, obtained by immunizing a subject mammal with an immunogen comprising at least one of heart muscle myosin light chain I and heart muscle myosin light chain II to provoke production of antibody by said mammal, recovering antibody containing serum therefrom, and immunosorptively removing said antibody from said serum by contacting said serum with a silicate based immunoadsorbent carrier containing skeletal muscle myosin light chain.
Claim 6
Dependent Claim
93 words
Process for obtaining a substantially pure antibody which specifically binds to heart muscle molecular light chain and has cross reactivity of less than 5% with skeletal muscle myosin light chain, comprising immunizing a subject mammal with an immunogen comprising at least one of heart muscle myosin light chain I and heart muscle myosin light chain II to provoke production of antibody by said mammal, recovering antibody containing serum therefrom, and immunosorptively removing said antibody from said serum by contacting said serum with a silicate based immunosorbent carrier containing skeletal muscle myosin light chain.
Claim 7
Dependent Claim
93 words
Process for obtaining a substantially pure antibody which specifically binds to heart muscle molecular light chain and has cross reactivity of less than 5% with skeletal muscle myosin light chain, comprising immunizing a subject mammal with an immunogen comprising at least one of heart muscle myosin light chain I and heart muscle myosin light chain II to provoke production of antibody by said mammal, recovering antibody containing serum therefrom, and immunosorptively removing said antibody from said serum by contacting said serum with a silicate based immunosorbent carrier containing skeletal muscle myosin light chain.
Claim 8
Dependent Claim
10 words
Process of claim 5, wherein said carrier is a gel.
Claim 9
Dependent Claim
22 words
Process of claim 5 or 6, wherein said skeletal muscle myosin light chain is coupled to said carrier by a bifunctional linker.
Claim 10
Dependent Claim
18 words
Process of claim 7, wherein said bifunctional linker is glutardialdehyde and said carrier is activated by amino groups.
Claim 11
Dependent Claim
25 words
Process of claim 7, wherein said skeletal muscle myosin light chain is bound to said carrier at a distance of no more than twenty atoms.
Claim 12
Dependent Claim
25 words
Monoclonal antibody which specifically binds to heart muscle myosin light chain and has cross reactivity of less than 5% against skeletal muscle myosin light chain.
Claim 13
Dependent Claim
25 words
Monoclonal antibody which specifically binds to heart muscle myosin light chain and has cross reactivity of less than 5% against skeletal muscle myosin light chain.
Claim 14
Dependent Claim
28 words
Monoclonal antibody of claim 10, selected from the group consisting of monoclonal antibody produced by hybridoma cell line 4D12 (ECACC 88022503) and hybridoma cell line 1B10 (ECACC 88022504).
Claim 15
Dependent Claim
30 words
Hybridoma cell line which produces monoclonal antibody which specifically binds to heart muscle myosin light chain and has cross reactivity with skeletal muscle myosin light chain of less than 5%.
Claim 16
Dependent Claim
30 words
Hybridoma cell line which produces monoclonal antibody which specifically binds to heart muscle myosin light chain and has cross reactivity with skeletal muscle myosin light chain of less than 5%.
Claim 17
Dependent Claim
19 words
Hybridoma cell line of claim 12, selected from the group consisting of 4D12 (ECACC 88022503) and 1B10 (ECACC 88022504).
Claim 18
Dependent Claim
15 words
Monoclonal antibody of claim 10, wherein said monoclonal antibody is conjugated to a determinable group.
Claim 19
Dependent Claim
39 words
Reagent for determining heart muscle myosin light chain comprising an antibody which specifically binds to heart muscle myosin light chain and has cross reactivity of less than 5% with skeletal muscle myosin light chain immobilized to a solid carrier.
Claim 20
Dependent Claim
39 words
Reagent for determining heart muscle myosin light chain comprising an antibody which specifically binds to heart muscle myosin light chain and has cross reactivity of less than 5% with skeletal muscle myosin light chain immobilized to a solid carrier.
Claim 21
Dependent Claim
24 words
Reagent of claim 15, further comprising a second antibody which carries a determinable group and which specifically binds to heart muscle myosin light chain.
Claim 22
Dependent Claim
11 words
Reagent of claim 15, wherein said antibody is a monoclonal antibody.
Claim 23
Dependent Claim
22 words
Reagent of claim 17, wherein said monoclonal antibody is produced by cell line 4D12 (ECACC 88022503) or cell line 1B10 (ECACC 88022504).
Claim 24
Dependent Claim
106 words
Method for determining heart muscle myosin light chain in a sample comprising contacting said sample with an immobilized antibody which specifically binds to heart muscle myosin light chain and has a cross reactivity of less than 5% against skeletal muscle myosin light chain and a monoclonal antibody which carries a determinable group and which specifically binds to heart muscle myosin light chain and has a cross reactivity of less than 5% against skeletal muscle myosin light chain, forming complexes between said antibodies and heart muscle myosin light chain and determining said determinable group in light or immobilized phase an indication of heart muscle myosin light chain.
Claim 25
Dependent Claim
106 words
Method for determining heart muscle myosin light chain in a sample comprising contacting said sample with an immobilized antibody which specifically binds to heart muscle myosin light chain and has a cross reactivity of less than 5% against skeletal muscle myosin light chain and a monoclonal antibody which carries a determinable group and which specifically binds to heart muscle myosin light chain and has a cross reactivity of less than 5% against skeletal muscle myosin light chain, forming complexes between said antibodies and heart muscle myosin light chain and determining said determinable group in light or immobilized phase an indication of heart muscle myosin light chain.
Claim 26
Dependent Claim
29 words
Method of claim 19, wherein said monoclonal antibody is selected from the group consisting of monoclonal antibody produced by hybridoma cell line 4D12 (ECACC 88022503) and 1B10 (ECACC 88022504).
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-11-06 | 1993-05-08 | 1993-11-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-11-06 | 1997-05-08 | 1997-11-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-11-06 | 2001-05-08 | 2001-11-07 | $7700.00 | Window Closed / Lapsed |